United States · Healthcare startup
United States · Shield Bio
Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting.
Funding reportedLast round: Pre-seed
About Shield Bio
Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting.
It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the treatment of infectious disease and address the unmet clinical need of sepsis, which kills 300,000 people a year in the US alone.
What company datasets say Shield Bio raised
Funding, as reported
Is this your company?
Add your raise, your deck and your story, and put Shield Bio in front of investors. Or tell us what we have wrong.